https://orcid.org/0000-0002-6770-0656
References
- Derouin F, Pelloux H. Parasitology ESGoC. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect. 2008;14:1089–1101.
- Basavaraju A. Toxoplasmosis in HIV infection: an overview. Trop Parasitol. 2016;6:129–135.
- Sumi M, Aosai F, Norose K, et al. Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients. Int J Hematol. 2013;98:214–222.
- Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143–1238.
- Damiani D, Stocchi R, Masolini P, et al. CD34+-selected versus unmanipulated autologous stem cell transplantation in multiple myeloma: impact on dendritic and immune recovery and on complications due to infection. Ann Oncol. 2003;14:475–480.
- Raser K, McNulty ML, Yanik G, et al. Pneumocystis jirovecii pneumonia in recipients of autologous hematopoietic stem cell transplantation: a 10-year cohort study. Blood. 2014;20:S116.
- Pagano L, Trape G, Putzulu R, et al. Toxoplasma gondii infection in patients with hematological malignancies. Ann Hematol. 2004;83:592–595.
- Gonzalez-Vicent M, Diaz MA, Sevilla J, et al. Cerebral toxoplasmosis following etanercept treatment for idiophatic pneumonia syndrome after autologous peripheral blood progenitor cell transplantation (PBPCT). Ann Hematol. 2003;82:649–653.
- Morjaria S, Epstein DJ, Romero FA, et al. Toxoplasma encephalitis in atypical hosts at an academic cancer center. Open Forum Infect Dis. 2016;3:ofw070.
- Nakane M, Ohashi K, Tominaga J, et al. Disseminated toxoplasmosis after CD34+-selected autologous peripheral blood stem cell transplantation. Haematologica. 2000;85:334–335.
- Scerra S, Coignard-Biehler H, Lanternier F, et al. Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review. Eur J Clin Microbiol Infect Dis. 2013;32:1259–1268.
- Straathof CS, Kortbeek LM, Roerdink H, et al. A solitary spinal cord toxoplasma lesion after peripheral stem-cell transplantation. J Neurol. 2001;248:814–815.
- Porrata LF, Litzow MR, Inwards DJ, et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma. Bone Marrow Transplant. 2004;33:291–298.
- Ahmad DS, Esmadi M, Steinmann WC. Idiopathic CD4 Lymphocytopenia: spectrum of opportunistic infections, malignancies, and autoimmune diseases. Avicenna J Med. 2013;3:37–47.
- Gajurel K, Gomez CA, Dhakal R, et al. Failure of primary atovaquone prophylaxis for prevention of toxoplasmosis in hematopoietic cell transplant recipients. Transpl Infect Dis. 2016;18:446–452.
- Urbancic KF, Ierino F, Phillips E, et al. Taking the challenge: a protocolized approach to optimize pneumocystis pneumonia prophylaxis in renal transplant recipients. Am J Transplant. 2018;18:462–466.